Solicitation of Nominations for Appointment to the Advisory Council for the Elimination of Tuberculosis, 26153-26154 [2024-07849]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 73 / Monday, April 15, 2024 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07847 Filed 4–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Board on
Radiation and Worker Health,
Subcommittee for Dose
Reconstruction Review, National
Institute for Occupational Safety and
Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Subcommittee
for Dose Reconstruction Review of the
Advisory Board on Radiation and
Worker Health (ABRWH or the Advisory
Board). This meeting is open to the
public, but without a public comment
period. The public is welcome to submit
written comments in advance of the
meeting, to the contact person below.
DATES: The meeting will be held on June
4, 2024, from 11 a.m. to 4 p.m., EDT.
Written comments must be received
on or before May 27, 2024.
ADDRESSES: You may submit comments
by mail to: Rashaun Roberts, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
24, Cincinnati, Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
Written comments received in
advance of the meeting will be included
in the official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the audio conference
(information below). The audio
conference line has 150 ports for callers.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for
Occupational Safety & Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–24,
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:44 Apr 12, 2024
Jkt 262001
Cincinnati, Ohio 45226, telephone:
(513) 533–6800, toll free 1(800) 232–
4636, email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
14109 on March 22, 2024. Unless
continued by the President the Board
will terminate on September 30, 2025,
consistent with E.O. 14109 of September
29, 2023.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
(DOE) facility who were exposed to
radiation but for whom it is not feasible
to estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class. SDRR is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor (Oak
Ridge Associated Universities—ORAU).
Matters to be Considered: The agenda
will include discussions on the
following: 1. Issues Resolution from Set
31. Facilities that may be covered
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
26153
include: Feed Materials Production
Center (FMPC), General Atomics,
General Electric Vallecitos, General
Steel Industries (South Plant), Hanford,
Idaho National Laboratory, Kansas City
Plant, Lawrence Livermore National
Laboratory, Los Alamos National
Laboratory, Metals and Controls Corp.,
Oak Ridge Gaseous Diffusion Plant (K–
25), Oak Ridge National Laboratory (X–
10), Pacific Northwest National
Laboratory, Paducah Gaseous Diffusion
Plant, Pantex Plant, Portsmouth Gaseous
Diffusion Plant, Rocky Flats Plant,
Sandia National Laboratories, Savannah
River Site, and Y–12 Plant; 2. Issues
resolution: Tab 585 from Set 29
(Pantex); 3. Report and further
discussion on changes to selection
criteria. Agenda items are subject to
change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07848 Filed 4–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Council for the Elimination of
Tuberculosis (ACET). ACET consists of
10 experts including the Chair in fields
associated with public health,
epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
SUMMARY:
E:\FR\FM\15APN1.SGM
15APN1
26154
Federal Register / Vol. 89, No. 73 / Monday, April 15, 2024 / Notices
tuberculosis, microbiology, and
preventive health care delivery.
DATES: Nominations for membership on
ACET must be received no later than
September 30, 2024. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
emailed to nchhstppolicy@cdc.gov with
the subject line ‘‘ACET 2025
Nomination.’’
FOR FURTHER INFORMATION CONTACT:
Marah Condit, M.S., Committee
Management Lead, Office of Policy,
Planning, and Partnerships, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop US8–6, Atlanta,
Georgia 30329–4027. Telephone: (404)
639–3423; email: nchhstppolicy@
cdc.gov.
The
Advisory Council for the Elimination of
Tuberculosis (ACET) provides advice
and recommendations regarding the
elimination of tuberculosis (TB) to the
Secretary, Department of Health and
Human Services (HHS); the Assistant
Secretary for Health, HHS; and the
Director, Centers for Disease Control
and Prevention (CDC). ACET (a) makes
recommendations on policies, strategies,
objectives, and priorities; (b) addresses
development and application of new
technologies; (c) provides guidance and
review of CDC’s TB prevention research
portfolio and program priorities; and (d)
reviews the extent to which progress has
been made toward eliminating TB.
Nominations are sought for persons
who have expertise and qualifications
necessary to contribute to the
accomplishment of the objectives of
ACET. Nominees will be selected on the
basis of their expertise in public health,
epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
tuberculosis, microbiology, or
preventive health care delivery. Federal
employees will not be considered for
membership. Members may be invited
to serve for up to four-year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACET
objectives.
HHS policy stipulates that committee
membership be balanced in terms of
points of view represented and the
committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
ddrumheller on DSK120RN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:44 Apr 12, 2024
Jkt 262001
and cannot be full-time employees of
the U.S. Government. Current
participation on Federal workgroups or
prior experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning of and annually during their
terms. CDC reviews potential candidates
for ACET membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2025, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Candidates should submit the
following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
and email address)
D At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (e.g., CDC,
National Institutes of Health, Food and
Drug Administration).
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate. CDC will
collect and retain nominations received
for up to two years to create a pool of
potential ACET nominees. When a
vacancy occurs, CDC will review
nominations and may contact nominees
at that time.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07849 Filed 4–12–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS 3453–FN]
Medicare Program; Application by the
Accreditation Commission for Health
Care (ACHC) for Continued CMS
Approval of Its Home Infusion Therapy
(HIT) Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), Health and
Human Services (HHS).
ACTION: Final Notice.
AGENCY:
This final notice announces
our decision to approve the
Accreditation Commission for Health
Care (ACHC) for continued recognition
as a national accrediting organization
that accredits suppliers of home
infusion therapy (HIT) services that
wish to participate in the Medicare or
Medicaid programs.
DATES: The approval announced in this
final notice is effective April 23, 2024,
through April 23, 2030.
FOR FURTHER INFORMATION CONTACT:
Shannon Freeland, (410) 786–4348,
shannon.freeland@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Home infusion therapy (HIT) is a
treatment option for Medicare
beneficiaries with a wide range of acute
and chronic conditions. Section 5012 of
the 21st Century Cures Act (Pub. L. 114–
255, enacted December 13, 2016) added
section 1861(iii) to the Social Security
Act (the Act), establishing a new
Medicare benefit for HIT services.
Section 1861(iii)(1) of the Act defines
‘‘home infusion therapy’’ as professional
services, including nursing services;
training and education not otherwise
covered under the Durable Medical
Equipment (DME) benefit; remote
monitoring; and other monitoring
services. Home infusion therapy must
be furnished by a qualified HIT supplier
and furnished in the individual’s home.
Sections 1861(iii)(A) and (B) of the Act
require that the individual (patient)
must:
• Be under the care of an applicable
provider (that is, physician, nurse
practitioner, or physician assistant); and
• Have a plan of care established and
periodically reviewed by a physician in
coordination with the furnishing of
home infusion drugs under Part B,
which prescribes the type, amount, and
duration of infusion therapy services
that are to be furnished.
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 89, Number 73 (Monday, April 15, 2024)]
[Notices]
[Pages 26153-26154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07849]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Council for the Elimination of Tuberculosis
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS), is seeking nominations for
membership on the Advisory Council for the Elimination of Tuberculosis
(ACET). ACET consists of 10 experts including the Chair in fields
associated with public health, epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
[[Page 26154]]
tuberculosis, microbiology, and preventive health care delivery.
DATES: Nominations for membership on ACET must be received no later
than September 30, 2024. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to [email protected]
with the subject line ``ACET 2025 Nomination.''
FOR FURTHER INFORMATION CONTACT: Marah Condit, M.S., Committee
Management Lead, Office of Policy, Planning, and Partnerships, National
Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6,
Atlanta, Georgia 30329-4027. Telephone: (404) 639-3423; email:
[email protected].
SUPPLEMENTARY INFORMATION: The Advisory Council for the Elimination of
Tuberculosis (ACET) provides advice and recommendations regarding the
elimination of tuberculosis (TB) to the Secretary, Department of Health
and Human Services (HHS); the Assistant Secretary for Health, HHS; and
the Director, Centers for Disease Control and Prevention (CDC). ACET
(a) makes recommendations on policies, strategies, objectives, and
priorities; (b) addresses development and application of new
technologies; (c) provides guidance and review of CDC's TB prevention
research portfolio and program priorities; and (d) reviews the extent
to which progress has been made toward eliminating TB.
Nominations are sought for persons who have expertise and
qualifications necessary to contribute to the accomplishment of the
objectives of ACET. Nominees will be selected on the basis of their
expertise in public health, epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics, tuberculosis, microbiology, or
preventive health care delivery. Federal employees will not be
considered for membership. Members may be invited to serve for up to
four-year terms. Selection of members is based on candidates'
qualifications to contribute to the accomplishment of ACET objectives.
HHS policy stipulates that committee membership be balanced in
terms of points of view represented and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on Federal workgroups or prior
experience serving on a Federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning of and annually
during their terms. CDC reviews potential candidates for ACET
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in July
2025, or as soon as the HHS selection process is completed. Note that
the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year.
Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, and email address)
[ssquf] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., CDC, National Institutes of
Health, Food and Drug Administration).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate. CDC will collect and retain
nominations received for up to two years to create a pool of potential
ACET nominees. When a vacancy occurs, CDC will review nominations and
may contact nominees at that time.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-07849 Filed 4-12-24; 8:45 am]
BILLING CODE 4163-18-P
